Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression.
Tsimikas S, Miyanohara A, Hartvigsen K, Merki E, Shaw PX, Chou MY, Pattison J, Torzewski M, Sollors J, Friedmann T, Lai NC, Hammond HK, Getz GS, Reardon CA, Li AC, Banka CL, Witztum JL.
Tsimikas S, et al. Among authors: witztum jl.
J Am Coll Cardiol. 2011 Oct 11;58(16):1715-27. doi: 10.1016/j.jacc.2011.07.017.
J Am Coll Cardiol. 2011.
PMID: 21982317
Free PMC article.